These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10763646)

  • 1. A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes.
    Young A; Topham C; Moore J; Turner J; Wardle J; Downes M; Evans V; Kay S
    Eur J Cancer Care (Engl); 1999 Sep; 8(3):154-61. PubMed ID: 10763646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mature results from three large controlled studies with raltitrexed ('Tomudex').
    Cunningham D
    Br J Cancer; 1998; 77 Suppl 2(Suppl 2):15-21. PubMed ID: 9579851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raltitrexed-based chemotherapy for advanced colorectal cancer.
    Liu Y; Wu W; Hong W; Sun X; Wu J; Huang Q
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):219-25. PubMed ID: 24388340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial.
    Ducreux M; Bouche O; Pignon JP; Mousseau M; Raoul JL; Cassan P; Leduc B; Berger C; Dunant A; Fournet J; Bedenne L;
    Oncology; 2006; 70(3):222-30. PubMed ID: 16816536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials.
    Cunningham D; Zalcberg J; Maroun J; James R; Clarke S; Maughan TS; Vincent M; Schulz J; González Barón M; Facchini T
    Eur J Cancer; 2002 Mar; 38(4):478-86. PubMed ID: 11872339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the tolerability of 'Tomudex' (raltitrexed): collective clinical experience in advanced colorectal cancer.
    Zalcberg J
    Anticancer Drugs; 1997 Aug; 8 Suppl 2():S17-22. PubMed ID: 9376633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group.
    Sato A; Kurihara M; Horikoshi N; Aiba K; Kikkawa N; Shirouzu K; Mitachi Y; Sakata Y; Wakui A
    Anticancer Drugs; 1999 Sep; 10(8):741-8. PubMed ID: 10573207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raltitrexed ('Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancer.
    Botwood N; James R; Vernon C; Price P
    Ann Oncol; 2000 Aug; 11(8):1023-8. PubMed ID: 11038040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trials.
    Schwartz GK; Harstrick A; González Barón M
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S9-13. PubMed ID: 10645208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial.
    Maughan TS; James RD; Kerr DJ; Ledermann JA; McArdle C; Seymour MT; Cohen D; Hopwood P; Johnston C; Stephens RJ;
    Lancet; 2002 May; 359(9317):1555-63. PubMed ID: 12047964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
    Cocconi G; Cunningham D; Van Cutsem E; Francois E; Gustavsson B; van Hazel G; Kerr D; Possinger K; Hietschold SM
    J Clin Oncol; 1998 Sep; 16(9):2943-52. PubMed ID: 9738562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck.
    Clarke SJ; Zalcberg J; Olver I; Mitchell PL; Rischin D; Dalley D; Green M; Davidson YE
    Ann Oncol; 2000 Feb; 11(2):239-41. PubMed ID: 10761765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas.
    Gebbia V; Verderame F; Ferraù F; Bordonaro R; Callari A; Caruso M; Tirrito ML; Valenza R; Cicero G; Borsellino N; Tralongo P
    Ann Oncol; 2006 Jun; 17 Suppl 7():vii60-5. PubMed ID: 16760296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ralitrexed (Tomudex) or Nordic-FLv regimen in metastatic colorectal cancer: a randomized phase II study focusing on quality of life, patients' preferences and health economics.
    Norum J; Balteskard L; Edna TH; Laino R; Wählby L; Rønning G
    J Chemother; 2002 Jun; 14(3):301-8. PubMed ID: 12120887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from raltitrexed--quality assurance, patient education and intensive supportive drugs to optimise tolerability.
    Thomas RJ; Williams M; Garcia-Vargas J
    Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):227-32. PubMed ID: 12924450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer.
    Schwartz GK; Bertino J; Kemeny N; Saltz L; Kelsen DK; Tong W; Welch M; Endres S; Dimery I
    Anticancer Drugs; 2004 Mar; 15(3):219-27. PubMed ID: 15014354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of infusional biomodulated 5-fluorouracil in metastatic colorectal cancer after raltitrexed failure.
    Decoster L; Neyns B; Akouaouach H; Fontaine C; Schallier D; De Grève JL
    Anticancer Res; 2004; 24(3b):2037-40. PubMed ID: 15274397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.
    Osterlund P; Orpana A; Elomaa I; Repo H; Joensuu H
    Br J Cancer; 2002 Sep; 87(6):591-9. PubMed ID: 12237767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raltitrexed. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
    Gunasekara NS; Faulds D
    Drugs; 1998 Mar; 55(3):423-35. PubMed ID: 9530547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of treating advanced colorectal cancer: a retrospective comparison of treatment regimens.
    Ross P; Heron J; Cunningham D
    Eur J Cancer; 1996; 32A Suppl 5():S13-7. PubMed ID: 8958037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.